Notícias Oric Pharmaceuticals Inc - ORIC | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Oric Pharmaceuticals Inc (ORIC)
Oric Pharmaceuticals Inc (ORIC) Notícias

Oric Pharmaceuticals Inc (ORIC)

7,03

-0,48

(-6,39%)

Fechado 22 Março 5:00PM

Atrasado por 15 minutos

7,03

0,005

(0,07%)

Após o horário de negociação: 7:52PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Form 8-K - Current report

ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

Form 8-K - Current report

ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones

ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations

ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Oric Pharmaceuticals

Sealand Capital Galaxy (CE)

Vontobel Financial Produ...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições